Concepedia

Davorka Tomic

DT

Statistics

Publications

2

Citations

44

H-Index

2

Active since

2024

Affiliations

NeuroRx Research (Canada)(Current)

Merck KGaA, Darmstadt (Germany)

McGill University

Davorka Tomic is an author at NeuroRx Research (Canada) specializing in relapsing-remitting multiple sclerosis treatment, bruton's tyrosine kinase inhibitors, and neuroscience.

Publications per year

2024–2024

2

Publications

2

Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis

Douglas L. Arnold, Colm Elliott, Emily C. Martin et al. · Neurology · 2024 · 28 citations · Full text

, , +17

Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study

Xavier Montalbán, Karolina Piasecka‐Stryczynska, Jens Kühle et al. · Multiple Sclerosis Journal · 2024 · 16 citations · Full text

, , +13

1–2 of 2